APLS vs CLX · rev $1.00B vs P/E 15, rev $7.10B
Apellis Pharmaceuticals Inc (APLS) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
The Clorox Company (CLX) is a household & personal products company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
APLS currently screens at market cap $2.29B. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the APLS and CLX stock pages for the full models.
Not investment advice.